Overview

Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

Status:
Completed

Trial end date:
2017-11-02

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of aflibercept for treatment of polypoidal choroidal vasculopathy without active polyp.

Phase:

Phase 4

Details

Lead Sponsor:

Samsung Medical Center

Collaborators:

Bayer
Kim's Eye Hospital
Seoul National University Bundang Hospital

Treatments:

Aflibercept
Endothelial Growth Factors